Supplemental Material from A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors
Authors:
- Afshin DowlatiADAfshin Dowlati
- Gordana VlahovicGVGordana Vlahovic
- Ronald B. NataleRNRonald B. Natale
- Erik RasmussenERErik Rasmussen
- Indrajeet SinghISIndrajeet Singh
- Yuying C. HwangYHYuying C. Hwang
- John RossiJRJohn Rossi
- Michael B. BassMBMichael B. Bass
- Gregory FribergGFGregory Friberg
- Cheryl A. PickettCPCheryl A. Pickett
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)